There are 4 articles on this title. You are reading the article ranked and rated #4 by Helium's members.
The next time you hear a company say that there recent "treatment" is one step closer to a "cure", You should consider the fallowing ...
First a question. What is the basic necessity that a company needs in order to survive? The answer should be obvious. To turn a profit. Without turning a profit a company can go bankrupt. Without turning a profit, a company cannot hope to out sell, out market, and do more research then there competitors.
Having said that. The following paragraph is why a pharmaceutical company is not necessarily interested in finding cures for diseases.
Say a company named "Cure Corp." developed the cure for aids while there competitors were only selling treatments. Suddenly the competing companies that sell treatments, would lose there market selling there treatments and have to move on to another diseases to provide treatments for. Hence why would some one continue to spend money on a treatment when they could buy the cure.
In one short paragraph I have summed up a very strong argument towards why pharmaceutical companies are not interested in finding cures for diseases. Pharmaceutical companies are not like other companies, if all they sold were cures the world may be a better place, but the pharmaceutical companies would also cease to exist.
By developing cures for diseases a company is in effect not selling the cure, but committing corporate suicide. That is to say that by selling the cure for aids Cure Corp. would be reducing it's customer base, intern reducing it's revenues, intern making it harder to compete with rival companies selling treatments for other diseases. Yes, Cure Corp. sells treatments for other diseases, but because it has sold off it's customer base with the cure for aids, it has left itself and all the other companies who sold treatments for aids, with less income, to produce those other treatments.
From a financial standpoint, finding cures for diseases is virtual means to an end. You have to question what kind of stock holders would put there money into a company that produces a product that would ultimately reduce it's profit's and result in the company filing for bankruptcy and shutting down.
And yes there will almost always be some kind of disease to be "cured" but without a treatment system that the infected person continually has to purchase. A company will only sell it's cure here and there as the disease pops up.
Now this brings up another very important realization because the reverse is also true.
Below are the top articles rated and ranked by Helium members on:
by Marie Davis
One of the major issues of this year's electoral campaign is health care. Most everyone agrees that our current syste... read more
There has been a lot of talk about the costs of health coverage and prescription drug costs lately. Clearly, with th... read more
Take an educated guess. Which American institution (not counting the Government) employs the most lawyers? The insura... read more
by Dean Lunz
The next time you hear a company say that there recent "treatment" is one step closer to a "cure", You should conside... read more
Add your voice
Know something about Corruption in America's pharmaceutical industry?
We want to hear your view.
Write now!
Already a member? Log in.
Cast your vote!
Click for your side.
Featured Partner
National Center for Policy Analysis (NCPA)
The National Center for Policy Analysis (NCPA) has partnered with Helium, giving you the chance to write for a cause....more
hide